A VC Quarter Like No Other

April 28, 2020

apple podcasts.png  google play.png  spotify.png  iheart.png

Q1 of 2020 began as a continuation of a strong 2019. But it became a whole new ballgame toward the end of the quarter when COVID-19 entered our lexicon. Alan Wink, Managing Director for EisnerAmper’s Capital Markets, gives his thoughts on the impact of the coronavirus on the VC world, how investors are changing their approach, and what we can expect in that now often-used phrase, the “new normal.”


Transcript

Dave Plaskow:Hello and welcome to the EisnerAmper Podcast series. Today we're taking a look at the Venture Capital landscape for the first quarter of 2020. I'm your host, Dave Plaskow, and with us, as always, is Alan Wink, a managing director for EisnerAmpers capital markets. Alan, welcome and thanks for being here.
Alan Wink:Good evening Dave, how are you?

DP:Good. So, Alan, I mean we've done these talks and these updates and these quarterly recaps for a few years now, but certainly the world became a different place around March of this year, courtesy of the coronavirus. Have you seen any corresponding impact on the VC world?
AW:I have to tell you, this has been an absolutely incredible stretch of, six to eight weeks, and someone said earlier today and I think it's so correct. We've literally seen 10 years of changes in 10 weeks. And it's just been an unbelievable period of time. And I think everyone, including the Venture Capital community is trying to find their way and get their bearings. It's funny, not that it's a good indicator for the rest of the year, but Q1 of 2020 was a good year for Venture Cap, a good quarter for Venture Capital. It was sort of on a par with, the prior two years where, we've had historic results. And still $34 billion of VC money invested in Q1. You have to remember, COVID-19 really didn't get hold of us until probably, the last couple of weeks of March. So it really didn't have a big impact on the first quarter, but I assume it's going to have dramatic effects for the rest of this year and way beyond as everyone realizes.
DP:Yeah, I would imagine so. So, it seems like in more tumultuous the times, the more investors go back to basics. I mean, I'm hearing that across a lot of different industries. And obviously it doesn't get more disruptive than a global pandemic. So, are we seeing a more conservative approach, at least in the short term for investments, and valuations, back to basics, solid balance sheets, liquidity, accurate valuations, that kind of thing?
AW:Well, I think the first part is going to be, in the Venture Capital space, there's still a tremendous amount of dry powder out there. I've seen estimates, above $150 billion of dry powder waiting to be invested. But I think the interesting thing from a VC standpoint is sort of their capital allocation. How much of that money is going to go towards, keeping their existing portfolio companies alive? How much capital is to be necessary to invest back in those companies versus new transactions? And I think we're also in an interesting age now, especially with, sheltering at home and social distancing. It's going to be interesting to see how VCs are going to do new deals when, they're having virtual meetings, they don't have a chance to really, spend a great deal of time in person with management teams and founders and entrepreneurs.

And you also have to deal with due diligence being done remotely. So, it's going to be interesting to see how VCs do new transactions. But the good news is that there's still a lot of dollars to be invested. I expect we're going to see a flight for quality in that VCs are going to be spending ... being much more cautious in terms of the deals that they do. And I think you're going to see dollars invested, but I think it might be a little slower than we've seen in past years.
DP:So Alan, look, there's nothing good about this pandemic. There are no silver linings. It's nothing but pain for so many people. But will we see any kind of innovation either on the tech side or biotech or pharma that comes out of this, that could do some good for some people down the road?
AW:Dave, I think there'll be amazing innovation that comes out of this. And, necessity is certainly a reason for innovation. It always has been in this country. And I think you're going to see some entrepreneurs develop technology that makes working at home more efficient. Technology for testing for the coronavirus and other viruses that might come into this country in the future. You're going to see pharmaceutical companies looking at remedies and cures for this virus. I think there's going to be some incredible innovation that occurs. And just, maybe to plug for a moment, EisnerAmper is actually hosting a webinar on April 29th. And we're fortunate enough to have four Venture capitalists from around the country on our panel, discussing the topic of how will VCs react to COVID-19. And talking about how they're looking at the investment climate today. And one of the questions that is certainly going to be discussed is, from these four venture capitalists are any companies in their existing portfolios going to be big winners as a result of this pandemic that we're all going through right now? So, there probably are some success stories that we're going to be hearing in the near future.
DP:Okay. One of the, I guess most overused phrases right now is "the new normal". I was talking to someone in the hospitality sector and they were saying, "Well, we can expect the new normal. This could be the death of things like cash. It could be the death of things like the Las Vegas buffet." When we talk about the VC landscape, and whatever the new normal is and whenever we get there, what do you think is going to be the lasting impact from all of this?
AW:One thing I should mention before we talk about the new normal is that, when you go back historically and look at, really difficult economic times. And probably the most recent was the period 2007, 2008, 2009. What was interesting from the VC perspective back then was that larger deals had a difficult time getting funded because valuations were so closely tied to the public markets and they were declining. Seed and earlier stage deals actually grew. And it's interesting that, through the first four months of 2020, the valuations for smaller deals has really increased. Not dramatically, but still on an upward trend. So it's going to be interesting to see what happens with this pandemic and, once again, I'm not sure you can look at the severity of this pandemic in the same light as the earlier economic events.

I think it's much more severe. The new normal is going to be interesting. It's rolling out as we speak. I think you're going to see VCs who are going to change their investment philosophy and their criteria. I think they're going to be looking in new areas. I think the new normal might include many more people, working from home and the technology that's going to facilitate that being done in an easier way. I think there's going to be much harder looks in the life sciences in terms of solutions to this pandemic and cures and for this pandemic and other viruses that might come down the road in the future. The world is going to be different, and it's going to be different in a lot of ways.
DP:Yep. Well, Alan thanks for your insight. And let's hope the better days are ahead.
AW:Thank you very much. One thing I hope all our listeners are at home, safe and sound.
DP:And thank you for listening to EisnerAmpers Podcast series. Visit eisneramper.com for more information on this and a host of other topics. And join us for our next EisnerAmper Podcast when we get down to business.

About Alan Wink

Mr. Wink assists clients with capital budgeting, capital structuring and capital sourcing. He has worked with many tech and life science companies on developing the appropriate capital structure for their position in the business life cycle.


More in This Series

VC Off to a Great Start in 2019
VC Off to a Great Start in 2019

A look at the venture capital landscape for the first quarter of 2019. In this podcast, EisnerAmper Director of Capital Markets Alan Wink looks at deal sizes, who’s on his IPO radar and if the good times will last. Will 2019 break last year’s record for venture capital investment?

Venture Capital Breaks a Record in 2018
Venture Capital Breaks a Record in 2018

EisnerAmper Director of Capital Markets Alan Wink discusses venture capital and the record-setting year for VC investment. From unicorn companies, the brisk IPO activity, fundraising and exit values, Alan discusses if VC investment can keep up this furious pace in 2019.

Are We on Track for a $100 Billion in VC Investment for 2018?
Are We on Track for a $100 Billion in VC Investment for 2018?

EisnerAmper's Director of Capital Markets examines venture capital VC investment for the third quarter (Q3) of 2018. Companies continue to raise large pools of private capital and 2019 might be the year of the IPO and climbing stock prices with Uber and Airbnb.

A Look at the NJ Innovation Evergreen Fund
A Look at the NJ Innovation Evergreen Fund

Governor Murphy’s Evergreen Fund in New Jersey will raise venture capital funding through tax credits. Companies in technology and life sciences can receive funding if the pass venture capital investor scrutiny and are located in New Jersey, providing little risk for investment.

Venture Capitals Tread Cautiously Due to High Valuations
Venture Capitals Tread Cautiously Due to High Valuations

This episode of EisnerAmper’s podcast series has the director of Capital Markets discuss the venture capital market for the first half of 2018, including fintech, valuations, M&A, artificial intelligence, IPO's, Apple's $1 billion valuation and the VC market in general.

More Than 40 Unicorns Lead Best VC Year Since the Dot-Com Era
More Than 40 Unicorns Lead Best VC Year Since the Dot-Com Era

In this episode of a “Quarterly Wink & a Glance at Venture Capital", Dave Plaskow and Alan Wink discuss the Q4 for 2017 and its effect on venture capital and private equity, as well as the rise of unicorn companies, concerns about over valuations, IPOs and capital markets.

Later-Stage Deals the Story of the Q3 2017 Venture Capital Market
Later-Stage Deals the Story of the Q3 2017 Venture Capital Market

Alan Wink gives us some highlights of the Q3 2017 venture capital market, including a noticeable lack of IPOs and exits. Venture capital markets are not reacting to proposed tax reform and there are concerns that public valuations might be lower, as signaled by Uber.